Picture of Natco Pharma logo

NATCOPHARM — Natco Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Natco Pharma Gives Update On USFDA Inspection At Manufacturing Facility In Kothur

April 9 (Reuters) - Natco Pharma Ltd  NATP.NS :
    * UPDATE ON USFDA INSPECTION AT NATCO'S MANUFACTURING
FACILITY IN
KOTHUR
    * COMPANY HAS RECEIVED A WARNING LETER DATED 8TH APRIL, 2024
FROM
UNITED STATES FOOD AND DRUG ADMINISTRATION
    * DOES NOT BELIEVE THAT WARNING LETER WILL HAVE IMPACT ON
DISRUPTION OF SUPPLIES OR EXISTING REVENUES FROM FACILITY
    * WARNING LETER MAY CAUSE DELAY/WITHHOLDING OF PENDING
PRODUCT
APPROVALS FROM THIS SITE

Source text for Eikon:  ID:nNSE7Ddz4H 
Further company coverage:  NATP.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Natco Pharma

See all news